Literature DB >> 1425837

Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions.

M C Sanchez-Fernandez de Sevilla1, L Morell-Quadreny, M Gil-Salom, M Perez-Bacete, A Llombart-Bosch.   

Abstract

We performed a morphometric and immunohistochemical study of 26 bladder carcinoma in situ (Cis) specimens, compared with normal urothelium and urothelial preneoplastic lesions. The following morphometric parameters were evaluated: nuclear area, nuclear perimeter and maximum nuclear diameter. For the immunohistochemical study we used five lectins, antibodies against four epithelial differentiation antigens, and antibodies against blood group isoantigens. A progressive increase in nuclear size from normal urothelium to dysplastic urothelium and Cis was detected. Nuclear size values in Cis and in high-grade, high-stage bladder carcinomas were similar. The most relevant immunohistochemical results were obtained with CEA, CK, UEA-1 and ABH isoantigens, which show significant immunoreactivity changes in preneoplastic urothelium and Cis when compared with normal urothelium. We conclude that bladder Cis behaves morphometrically and immunohistochemically as an invasive bladder carcinoma, and we emphasize the usefulness of these techniques for detecting flat dysplastic and neoplastic lesions in random bladder biopsies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425837     DOI: 10.1159/000474878

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

1.  Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.

Authors:  M Rita I Young
Journal:  J Immunother       Date:  2008 Feb-Mar       Impact factor: 4.456

2.  Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome.

Authors:  Kara A Lombardo; Belkiss Murati Amador; Vamsi Parimi; Jean Hoffman-Censits; Woonyoung Choi; Noah M Hahn; Max Kates; Trinity J Bivalacqua; David McConkey; Mohammad O Hoque; Andres Matoso
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.